No Detail Found!

Prevalence of Non-alcoholic Fatty Liver Disease in the Patients Suffering from Diabetes Mellitus Type Ii.

Author(s)
Muhammad Mumtaz Athar Bakhtawar Amin Medical & Dental College, Multan, Pakistan
Talha Rasheeq Bakhtawar Amin Medical & Dental College, Multan, Pakistan
Muddasar Ahmed Bakhtawar Amin Medical & Dental College, Multan, Pakistan
Aamir Furqan Nishtar Medical University, Multan, Pakistan
Abstract
OBJECTIVE: To assess the prevalence of non-alcoholic fatty liver disease in type II diabetes mellitus patients. STUDY DESIGN: A Prospective Observational Study PLACE AND DURATION: Department of Medicine Nishtar Hospital Multan, from 1st April, 2017 to 1st January, 2018. METHODOLOGY: Patients presenting with diabetes mellitus type II were divided into two equal groups on the basis of presence or absence of non alcoholic fatty liver disease. Age, gender, BMI, Plasma aspartate aminotransferase, Plasma alanine aminotransferase, Plasma alkaline phosphatase, duration of type II diabetes mellitus, fasting plasma glucose, serum albumin, plasma cholesterol, plasma triglycerides, Plasma LDL-C, Plasma HDL-C and HbA1c were the variables calculated. RESULTS: The mean age was 59.15±5.63 years, BMI 32.03±5.32 kg/m2, Plasma AST 19.68±2.22, Plasma ALT 19.87±1.71, Plasma ALP 62.32±12.84, duration of type 2 DM was 8.40±3.71 years and fasting plasma glucose of non NAFLD patients was 124.57±5.66 mg/dl. While, the mean age was 61.55±8.00 years, BMI 32.05±6.24 kg/m2, plasma AST 23.03±2.56, plasma ALT 27.28±1.94, plasma ALP 75.19±21.30, duration of type 2 DM 8.12±1.28 years and fasting plasma glucose of NAFLD patients was 137.45±5.07 mg/dl. The mean albumin (g/dl) was 4.20±0.64 g/dl, plasma cholesterol was 150.65±28.44, plasma triglyceride 114.04±5.99, plasma LDL-C 87.25±18.16 and plasma HDL-C of non NAFLD patients was 42.97±11.40. HbA1c in non NAFLD was 9.1%. While, the mean albumin was (g/dl) 3.80±0.69 g/dl, plasma cholesterol 158.62±42.02, plasma triglyceride 150.07±9.03, plasma LDL-C 87.0±27.89 and plasma HDL-C of NAFLD patients was 40.76±10.46. HbA1c of NAFLD patients was 6.8%. CONCLUSION: Non Alcoholic Fatty Liver Disease has a high prevalence in patients with type II diabetes mellitus having normal aminotransferases.
Publication Details
Page(s) 263-266
DOI DOI not available
Published Journal: Isra Medical Journal, Volume: 10, Issue: 5, Year: 2018

Request the full text from PASTIC

References
BellentaniS., 2017.The epidemiology of non‐alcoholic fatty liver disease,Liver Int 37 81 -84
Yki-Järvinen H, 2016.Diagnosis of non-alcoholic fatty liver disease (NAFLD),Diabetologia 59 1104 -11
LazoM,HernaezR,EberhardtMS,BonekampS,KamelI,GuallarE, 2013.Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey,, 178 38 -45
SzczepaniakLS,NurenbergP,LeonardD,BrowningJD,ReingoldJS,GrundyS, 2005.Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population,Am J Physiol Endocrinol Metab 288 E462 -8
LoombaR,SanyalAJ, 2013.The global NAFLD epidemic,Nat Rev Gastroenterol Hepatol 10 686 -
BirkenfeldAL,ShulmanGI, 2014.Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes,Hepatol 59 713 -23
GanzM,SzaboG, 2013.Immune and inflammatory pathways in NASH,Hepatol int 7 771 -81
SchwengerKJ,AllardJP., 2014.Clinical approaches to nonalcoholic fatty liver disease,Worl j gastroenterol: WJG 20 1712 -
Portillo-SanchezP,BrilF,MaximosM,LomonacoR,BiernackiD,OrsakB, 2015.High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels,J Clin Endocrinol Metab 100 2231 -38
CusiK., 2012.Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications,Gastroenterol 142 711 -25
TolmanKG,FonsecaV,DalpiazA,TanMH, 2007.Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease,Diabetes Care 30 734 -43
TargherG,MantovaniA,PichiriI,MingollaL,CavalieriV,MantovaniW, 2014.Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes,Diabetes Care 37 1729 -36
TargherG,MarraF,MarchesiniG, 2008.Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?,Diabetologia 51 1947 -53
VillanovaN,MoscatielloS,RamilliS,BugianesiE,MagalottiD,VanniE, 2005.Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease,Hepatol 42 473 -80
ParkSK,SeoMH,ShinHC,RyooJH., 2013.Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5‐year prospective cohort study,Hepatol 57 1378 -83
BaeJC,RheeEJ,LeeWY,ParkSE,ParkCY,OhKW, 2011.Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study,Diabetes Care 34 727 -29
RyanCK,JohnsonLA,GerminBI,MarcosA, 2002.One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation,Liver transplant 8 1114 -22
FracanzaniAL,ValentiL,BugianesiE,AndreolettiM,ColliA,VanniE, 2008.Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes,Hepatol 48 792 -98
MofradP,ContosMJ,HaqueM,SargeantC,FisherRA,LuketicVA, 2003.Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values,Hepatol 37 1286 -92
0

Citations

0

Downloads

29

Views